Cargando…

DAPK1 Signaling Pathways in Stroke: from Mechanisms to Therapies

Death-associated protein kinase 1 (DAPK1), a Ca(2+)/calmodulin (CaM)-dependent serine/threonine protein kinase, plays important roles in diverse apoptosis pathways not only in tumor suppression but also in neuronal cell death. The requirement of DAPK1 catalytic activity for its proposed cell functio...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shan, Shi, Xiangde, Li, Hao, Pang, Pei, Pei, Lei, Shen, Huiyong, Lu, Youming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509806/
https://www.ncbi.nlm.nih.gov/pubmed/27447806
http://dx.doi.org/10.1007/s12035-016-0008-y
_version_ 1783250079207915520
author Wang, Shan
Shi, Xiangde
Li, Hao
Pang, Pei
Pei, Lei
Shen, Huiyong
Lu, Youming
author_facet Wang, Shan
Shi, Xiangde
Li, Hao
Pang, Pei
Pei, Lei
Shen, Huiyong
Lu, Youming
author_sort Wang, Shan
collection PubMed
description Death-associated protein kinase 1 (DAPK1), a Ca(2+)/calmodulin (CaM)-dependent serine/threonine protein kinase, plays important roles in diverse apoptosis pathways not only in tumor suppression but also in neuronal cell death. The requirement of DAPK1 catalytic activity for its proposed cell functions and the elevation of catalytic activity of DAPK1 in injured neurons in models of neurological diseases, such as ischemia and epilepsy, validate that DAPK1 can be taken as a potential therapeutic target in these diseases. Recent studies show that DAPK1-NR2B, DAPK1-DANGER, DAPK1-p53, and DAPK1-Tau are currently known pathways in stroke-induced cell death, and blocking these cascades in an acute treatment effectively reduces neuronal loss. In this review, we focus on the role of DAPK1 in neuronal cell death after stroke. We hope to provide exhaustive summaries of relevant studies on DAPK1 signals involved in stroke damage. Therefore, disrupting DAPK1-relevant cell death pathway could be considered as a promising therapeutic approach in stroke.
format Online
Article
Text
id pubmed-5509806
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-55098062017-07-28 DAPK1 Signaling Pathways in Stroke: from Mechanisms to Therapies Wang, Shan Shi, Xiangde Li, Hao Pang, Pei Pei, Lei Shen, Huiyong Lu, Youming Mol Neurobiol Article Death-associated protein kinase 1 (DAPK1), a Ca(2+)/calmodulin (CaM)-dependent serine/threonine protein kinase, plays important roles in diverse apoptosis pathways not only in tumor suppression but also in neuronal cell death. The requirement of DAPK1 catalytic activity for its proposed cell functions and the elevation of catalytic activity of DAPK1 in injured neurons in models of neurological diseases, such as ischemia and epilepsy, validate that DAPK1 can be taken as a potential therapeutic target in these diseases. Recent studies show that DAPK1-NR2B, DAPK1-DANGER, DAPK1-p53, and DAPK1-Tau are currently known pathways in stroke-induced cell death, and blocking these cascades in an acute treatment effectively reduces neuronal loss. In this review, we focus on the role of DAPK1 in neuronal cell death after stroke. We hope to provide exhaustive summaries of relevant studies on DAPK1 signals involved in stroke damage. Therefore, disrupting DAPK1-relevant cell death pathway could be considered as a promising therapeutic approach in stroke. Springer US 2016-07-22 2017 /pmc/articles/PMC5509806/ /pubmed/27447806 http://dx.doi.org/10.1007/s12035-016-0008-y Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Article
Wang, Shan
Shi, Xiangde
Li, Hao
Pang, Pei
Pei, Lei
Shen, Huiyong
Lu, Youming
DAPK1 Signaling Pathways in Stroke: from Mechanisms to Therapies
title DAPK1 Signaling Pathways in Stroke: from Mechanisms to Therapies
title_full DAPK1 Signaling Pathways in Stroke: from Mechanisms to Therapies
title_fullStr DAPK1 Signaling Pathways in Stroke: from Mechanisms to Therapies
title_full_unstemmed DAPK1 Signaling Pathways in Stroke: from Mechanisms to Therapies
title_short DAPK1 Signaling Pathways in Stroke: from Mechanisms to Therapies
title_sort dapk1 signaling pathways in stroke: from mechanisms to therapies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509806/
https://www.ncbi.nlm.nih.gov/pubmed/27447806
http://dx.doi.org/10.1007/s12035-016-0008-y
work_keys_str_mv AT wangshan dapk1signalingpathwaysinstrokefrommechanismstotherapies
AT shixiangde dapk1signalingpathwaysinstrokefrommechanismstotherapies
AT lihao dapk1signalingpathwaysinstrokefrommechanismstotherapies
AT pangpei dapk1signalingpathwaysinstrokefrommechanismstotherapies
AT peilei dapk1signalingpathwaysinstrokefrommechanismstotherapies
AT shenhuiyong dapk1signalingpathwaysinstrokefrommechanismstotherapies
AT luyouming dapk1signalingpathwaysinstrokefrommechanismstotherapies